LumiraDx Ltd
NASDAQ:LMDX
LumiraDx Ltd
Income from Continuing Operations
LumiraDx Ltd
Income from Continuing Operations Peer Comparison
Competitive Income from Continuing Operations Analysis
Latest Figures & CAGR of Competitors
Company | Income from Continuing Operations | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
LumiraDx Ltd
NASDAQ:LMDX
|
Income from Continuing Operations
-$447.6m
|
CAGR 3-Years
-50%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Smith & Nephew PLC
LSE:SN
|
Income from Continuing Operations
$263m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
LivaNova PLC
NASDAQ:LIVN
|
Income from Continuing Operations
-$31.7m
|
CAGR 3-Years
58%
|
CAGR 5-Years
32%
|
CAGR 10-Years
N/A
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Income from Continuing Operations
£2.7m
|
CAGR 3-Years
-38%
|
CAGR 5-Years
-23%
|
CAGR 10-Years
N/A
|
|
Angle PLC
LSE:AGL
|
Income from Continuing Operations
-£22.3m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Creo Medical Group PLC
LSE:CREO
|
Income from Continuing Operations
-£26.9m
|
CAGR 3-Years
-19%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is LumiraDx Ltd's Income from Continuing Operations?
Income from Continuing Operations
-447.6m
USD
Based on the financial report for Dec 31, 2022, LumiraDx Ltd's Income from Continuing Operations amounts to -447.6m USD.
What is LumiraDx Ltd's Income from Continuing Operations growth rate?
Income from Continuing Operations CAGR 3Y
-50%
Over the last year, the Income from Continuing Operations growth was -344%. The average annual Income from Continuing Operations growth rates for LumiraDx Ltd have been -50% over the past three years .